Frequency Analysis of Coronary Artery Disease

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

University of Minnesota - Clinical and Translational Science Institute

ClinicalTrials.gov Identifier:

NCT01043237

First received: January 4, 2010

Last updated: September 3, 2014

Last verified: September 2014

History of Changes

Purpose

The purpose of this study is to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument. The presence or absence of abnormal pathology will be confirmed by diagnostic angiography as part of the normal patient care at this institution.

Condition
Coronary Artery Disease


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	A Single-centered Investigation Into the Frequency Domain Patterns in Vessels of Patients With Coronary Artery Disease

Resource links provided by NLM:

MedlinePlus related topics: Coronary Artery Disease

U.S. FDA Resources

Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:

to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument [ Time Frame: Baselin ]
to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument


Enrollment:	330
Study Start Date:	March 2009
Study Completion Date:	March 2013
Primary Completion Date:	March 2013 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	18 Years to 89 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients presenting to the University of Minnesota Medical Center (UMMC) Fairview Clinics, Physicians (UMP) or the Redwing, Minnesota clinic

Criteria

Inclusion Criteria:

Patients aged 18-89 years old and recommended for a cardiology related angiogram within 24 hours

Exclusion Criteria:

Any patient less than 18 years of age or greater than 89 years of age.
Any patient with any of the following conditions: pregnant or nursing, prior myocardial infarction, left ventricular device, heart transplant, valve replacement, congestive heart failure, atrial fibrillation (non-intermittent), endocarditis or any heart viral or bacterial infection, any patient who has or requires medication or other heart rhythm altering treatment.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01043237

Locations


United States, Minnesota
University of Minnesota Medical Center (UMMC) Fairview Clinics
Minneapolis, Minnesota, United States, 55455

Sponsors and Collaborators

University of Minnesota - Clinical and Translational Science Institute

Investigators


Principal Investigator:	Robert Wilson, MD	University of Minnesota - Clinical and Translational Science Institute

More Information


Responsible Party:	University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:	NCT01043237 History of Changes
Other Study ID Numbers:	0901M57884
Study First Received:	January 4, 2010
Last Updated:	September 3, 2014

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:


acoustic digital sound vibration	coronary auscultation artery diagnosis

Additional relevant MeSH terms:


Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases	Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases

ClinicalTrials.gov processed this record on June 22, 2017

To Top